These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7296554)

  • 1. Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration.
    Unverferth DV; Magorien RD; Unverferth BP; Talley RL; Balcerzak SP; Baba N
    Cancer Treat Rep; 1981; 65(11-12):1093-7. PubMed ID: 7296554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine.
    Unverferth DV; Jagadeesh JM; Unverferth BJ; Magorien RD; Leier CV; Balcerzak SP
    J Natl Cancer Inst; 1983 Nov; 71(5):917-20. PubMed ID: 6580492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
    Torti FM; Bristow MM; Lum BL; Carter SK; Howes AE; Aston DA; Brown BW; Hannigan JF; Meyers FJ; Mitchell EP
    Cancer Res; 1986 Jul; 46(7):3722-7. PubMed ID: 3458531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endomyocardial biopsy as a method of surveilling adriamycin cardiac toxicity. 28 biopsies in 26 patients].
    Bouhour JB; Petitier H; Delajartre AY; Fumoleau P; Rozo L; Nicolas G
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1277-83. PubMed ID: 6419695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin affects both the number and the morphology of specific atrial granules in dog heart.
    Bellini O; Danesi R; Bernardini N; Cardini G; Marzilli M; del Tacca M
    Anticancer Res; 1988; 8(4):599-604. PubMed ID: 3178151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early changes in human myocardial nuclei after doxorubicin.
    Unverferth BJ; Magorien RD; Balcerzak SP; Leier CV; Unverferth DV
    Cancer; 1983 Jul; 52(2):215-21. PubMed ID: 6861067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
    Unverferth DV; Leier CV; Magorien RD; Croskery R; Svirbely JR; Kolibash AJ; Dick MR; Meacham JA; Baba N
    J Pharmacol Exp Ther; 1980 Nov; 215(2):527-32. PubMed ID: 7441513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
    Jaenke RS
    Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin cardiomyopathy: pathological and membrane functional changes in a canine model with mild impairment of left ventricular function.
    Tomlinson CW; McGrath GM; McNeill JH
    Can J Cardiol; 1986; 2(6):368-74. PubMed ID: 3801966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural alterations of the myocardium induced by doxorubicin. A scanning electron microscopic study.
    Iwasaki T; Suzuki T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(1):35-9. PubMed ID: 1673275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometry and autoradiography of early hypertrophic changes in the ventricular myocardium of adult rat: an electron microscopic study.
    Anversa P; Loud AV; Vitali-Mazza L
    Lab Invest; 1976 Nov; 35(5):475-83. PubMed ID: 136547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myocardial ultrastructure of rats exposed aboard biosatellite "Cosmos-936"].
    Rokhlenko KD; Mul'diiarov PIa
    Kosm Biol Aviakosm Med; 1981; 15(1):77-82. PubMed ID: 7218755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy.
    Takaseya T; Ishimatsu M; Tayama E; Nishi A; Akasu T; Aoyagi S
    J Am Coll Cardiol; 2004 Dec; 44(11):2239-46. PubMed ID: 15582323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post mortem, ultrastructural cardiac muscle changes and anthracycline toxicity.
    Andersson B; Collins VP
    Biomed Pharmacother; 1983; 37(6):281-7. PubMed ID: 6367847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts.
    Tatsumi T; Akashi K; Keira N; Matoba S; Mano A; Shiraishi J; Yamanaka S; Kobara M; Hibino N; Hosokawa S; Asayama J; Fushiki S; Fliss H; Nakagawa M; Matsubara H
    J Mol Cell Cardiol; 2004 Sep; 37(3):775-84. PubMed ID: 15350850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-induced alterations in the rabbit heart.
    Clark AF; Tandler B; Vignos PJ
    Lab Invest; 1982 Dec; 47(6):603-10. PubMed ID: 7144140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac evaluation of mitoxantrone.
    Unverferth DV; Unverferth BJ; Balcerzak SP; Bashore TA; Neidhart JA
    Cancer Treat Rep; 1983 Apr; 67(4):343-50. PubMed ID: 6850653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in left ventricular function during chemotherapy with doxorubicin].
    Elbl L; Chaloupka V; Vásová I; Kiss I; Jancík J; Vorlícek J; Navrátil M
    Vnitr Lek; 1999 Jul; 45(7):395-402. PubMed ID: 11045157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.